Canadian application, no grantCanada
The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
CA 2446049 A1 · Owner: Kirk, Ian · Inventors: Kirk, Ian
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
According to the invention there is provided the use of a gatran such as , inogatran or melagatran, or a pharmaceutically-acceptable derivative thereof for the manufacture of a medicament for the treatment of pulmonary fibrosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 16, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 16, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 16, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 16, 2002
GrantedNo grant recorded
Term endedMay 16, 2022
Patent numberCA 2446049 A1
Classification (IPC)A61K38/05 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.